Fidelity Investments
GNCA

Fidelity Investments’s Genocea Biosciences, Inc. GNCA Stock Holding History

Fidelity Investments’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-60,565
Closed -$509K – 2775
2018
Q1 		$509K Buy
60,565
+225
+0.4% +$1.87K ﹤0.01% 2513
2017
Q4 		$560K Sell
60,340
-52,623
-47% -$529K ﹤0.01% 2511
2017
Q3 		$1.32M Sell
112,963
-421,502
-79% -$16M ﹤0.01% 2386
2017
Q2 		$22.3M Buy
534,465
+114
+0% +$5.49K ﹤0.01% 1635
2017
Q1 		$26M Buy
534,351
+2,322
+0.4% +$90.7K ﹤0.01% 1583
2016
Q4 		$17.5M Hold
532,029
– – ﹤0.01% 1733
2016
Q3 		$21.8M Buy
532,029
+1,524
+0.3% +$59.8K ﹤0.01% 1636
2016
Q2 		$17.4M Buy
530,505
+2,644
+0.5% +$96.9K ﹤0.01% 1742
2016
Q1 		$32.7M Buy
527,861
+704
+0.1% +$22.4K ﹤0.01% 1430
2015
Q4 		$22.2M Buy
527,157
+1,027
+0.2% +$48.9K ﹤0.01% 1643
2015
Q3 		$28.8M Buy
526,130
+73,326
+16% +$7.27M ﹤0.01% 1498
2015
Q2 		$49.7M Buy
452,804
+15,799
+4% +$1.47M 0.01% 1340
2015
Q1 		$41.5M Buy
437,005
+106,815
+32% +$7.54M 0.01% 1416
2014
Q4 		$18.5M Buy
330,190
+3,775
+1% +$258K ﹤0.01% 1770
2014
Q3 		$23.6M Buy
326,415
+1,582
+0.5% +$173K ﹤0.01% 1669
2014
Q2 		$48.7M Buy
324,833
+116,041
+56% +$17.6M 0.01% 1349
2014
Q1 		$30.4M Buy
+208,792
New +$25.6M ﹤0.01% 1569

Other funds holding GNCA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments's GNCA Position: Q2 2018 in Review

Fidelity Investments sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2018, closing a stake of 60,565 shares — an estimated $509K sold.

Fidelity Investments first reported a position in GNCA in Q1 2014 and held it in 17 quarters. The position peaked at $49.7M in Q2 2015. 54 funds tracked by Wall St. Rank hold GNCA as of Q2 2018.

  • Fidelity Investments reported no remaining Genocea Biosciences, Inc. position as of Q2 2018 after selling out during the quarter.
  • Fidelity Investments sold 60,565 Genocea Biosciences, Inc. shares in Q2 2018, an estimated $509K.
  • Fidelity Investments first reported a position in Genocea Biosciences, Inc. in Q1 2014 and held it in 17 quarters.
  • Fidelity Investments's Genocea Biosciences, Inc. position peaked at $49.7M in Q2 2015.
  • 54 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2018.

Based on Fidelity Investments's 13F filing for Q2 2018, filed 10 Aug 2018.